- Is- sustanza attiva hi immunoglobulin normali uman (IVIg).
http://www.emea.europa.eu/

- The active substance is human normal immunoglobulin (IVIg).
http://www.emea.europa.eu/

Flebogammadif 50 mg/ ml soluzzjoni għall- infużjoni Immunoglobulin normali uman
http://www.emea.europa.eu/

Flebogammadif 50 mg/ ml solution for infusion Human normal immunoglobulin
http://www.emea.europa.eu/

immunoglobulin normali uman (IVIg), li minnu, mill- anqas 97% hi IgG.
http://www.emea.europa.eu/

human normal immunoglobulin, of which at least 97% is IgG.
http://www.emea.europa.eu/

- jekk għandek defiċjenza ta ’ immunoglobulin A (IgA) ma ’ antikorpi anti- IgA.
http://www.emea.europa.eu/

- if you have immunoglobulin A (IgA) deficiency with anti-IgA antibodies.
http://www.emea.europa.eu/

Flebogammadif 50 mg/ ml soluzzjoni għall- infużjoni Immunoglobulin normali umana Użu għal ġol- vini
http://www.emea.europa.eu/

Flebogammadif 50 mg/ ml solution for infusion Human normal immunoglobulin For intravenous use
http://www.emea.europa.eu/

- jekk inti allerġiku/ a (tbati minn sensittività eċċessiva) għal immunoglobulin normali uman jew
http://www.emea.europa.eu/

- if you are allergic (hypersensitive) to human normal immunoglobulin or any of the other
http://www.emea.europa.eu/

- li l- pazjenti ma jkunux sensittivi għal immunoglobulin normali uman billi l- ewwel tinjetta l -
http://www.emea.europa.eu/

- that patients are not sensitive to human normal immunoglobulin by first injecting the product
http://www.emea.europa.eu/

- f’ pazjenti li jirċievu immunoglobulin normali uman għall- ewwel darba, jew f’ każijiet rari, meta
http://www.emea.europa.eu/

- in patients who receive human normal immunoglobulin for the first time, or in rare cases, when
http://www.emea.europa.eu/

Għandu distribuzzjoni ta 'sottoklassijiet ta' l- immunoglobulin G proporzjonali sew għal dik fil- plażma nativa umana.
http://www.emea.europa.eu/

It has a distribution of immunoglobulin G subclasses closely proportional to that in native human plasma.
http://www.emea.europa.eu/

Millilitru wieħed fih 50 mg ta ’ immunoglobulin normali uman (IVIg), li minnu, mill- anqas 97% hu IgG.
http://www.emea.europa.eu/

One ml contains 50 mg of human normal immunoglobulin (IVIg) of which at least 97% is IgG.
http://www.emea.europa.eu/

Millilitru wieħed fih 50 mg ta ’ immunoglobulin normali uman (IVIg), li minnha, mill- anqas 97% hi IgG.
http://www.emea.europa.eu/

One ml contains 50 mg of human normal immunoglobulin (IVIg) of which at least 97% is IgG.
http://www.emea.europa.eu/

L- immunoglobulin normali uman primarjament fih immunoglobulin G (IgG) b’ firxa wiesgħa ta ’ antikorpi kontra organiżmi infettivi.
http://www.emea.europa.eu/

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents.
http://www.emea.europa.eu/

Il- kura bl- immunoglobulin normali uman jista ’ jintuża bħala parti mill- kors ta ’ kondizzjonar u wara t - trapjant.
http://www.emea.europa.eu/

Human normal immunoglobulin treatment can be used as part of the conditioning regimen and after the transplant.
http://www.emea.europa.eu/

l- prodott ta ’ l- immunoglobulin normali uman jinbidel ma ’ ieħor, jew meta kien hemm intervall twil mill- aħħar infużjoni.
http://www.emea.europa.eu/

the human normal immunoglobulin product is switched or when there has been a long interval since the previous infusion.
http://www.emea.europa.eu/

It- trattament b’ Xolair għandu jkun ikkunsidrat għal pazjenti li l- ażżma tagħhom tkun ikkawżata minn IgE (immunoglobulin E, antikorp).
http://www.emea.europa.eu/

Xolair treatment should only be considered for patients whose asthma is caused by IgE (immunoglobulin E, an antibody).
http://www.emea.europa.eu/

Żid kontroll wieħed PBS fuq is-slide tat-test sabiex tistabbilixxi jekk il-fluorescein isothiocyanate anti-rabbit immunoglobulin conjugate (FITC) jitħallatx maċ-ċelloli tal-bakterja.

Include one PBS control on the test slide to determine whether the fluorescein isothiocyanate anti-rabbit immunoglobulin conjugate (FITC) combines non-specifically with bacterial cells.

Dożi adegwati ta 'immunoglobulina normali umana jistgħu jgħollu l- livelli baxxi mhux normali ta' l- immunoglobulin G għall- medda normali.
http://www.emea.europa.eu/

Adequate doses of human normal immunoglobulin may restore abnormally low immunoglobulin G levels to the normal range.
http://www.emea.europa.eu/

Kontenituri f’ platti mikrotitri huma miksija mal-lejl b’ taħlitiet rakkmandat ta’ immunoglobulin purifikat ishma żgħar ta’ antikorpi ta’ kwalita’ ta’referenza.

Wells in microtitre plates are coated overnight with recommended dilutions of purified immunoglobulin fractions of antibodies of reference quality.

Alemtużumab kien ġenerat bl- inserzjoni ta ’ sitt reġjuni li jiddeterminaw il- kumplimentarità minn antikorp monoklonali IgG2a tal- firien f’ molekula immunoglobulin IgG1 umana.
http://www.emea.europa.eu/

Alemtuzumab was generated by the insertion of six complementarity-determining regions from an IgG2a rat monoclonal antibody into a human IgG1 immunoglobulin molecule.
http://www.emea.europa.eu/

Ma ħareġ l- ebda tagħrif dwar it- teħid ta ’ Ambirix flimkien ma 'immunoglobulin speċifiku ta ’ l- epatite A jew immunoglobulin speċifiku ta' l- epatite B.
http://www.emea.europa.eu/

No data on concomitant administration of Ambirix with specific hepatitis A immunoglobulin or hepatitis B immunoglobulin have been generated.
http://www.emea.europa.eu/